Clinical Trial Update: Comparison of the Efficacy, Safety, and Relapse of ECT to ECT Plus Agomelatine for Depressed Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing electroconvulsive therapy (ECT) alone versus ECT plus agomelatine for major depressive disorder; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Agomelatine (agomelatine)
• electroconvulsive therapy (ECT) (electroconvulsive therapy)

Snippet

Sponsor: Kaohsiung Kai-Suan Psychiatric Hospital | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED